Cargando…
Preparation, characterisation, and in vitro cancer‐suppression function of RNA nanoparticles carrying miR‐301b‐3p Inhibitor
BACKGROUND: Multidrug resistance is the biggest barrier on the way to chemotherapy for lung adenocarcinoma (LUAD). For some LUAD patients with cisplatin (DDP) resistance and poor prognoses, the authors put forward RNA nanoparticles (NPs) carrying miR‐301b‐3p Inhibitor. METHODS: The NPs were composed...
Autores principales: | Zhao, Junjie, Niu, Niu, Yang, Fan, Liu, Haitao, Qi, Weibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190642/ https://www.ncbi.nlm.nih.gov/pubmed/36892102 http://dx.doi.org/10.1049/nbt2.12120 |
Ejemplares similares
-
MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation,
Migration and Invasion by Targeting DLC1
por: Liu, Haitao, et al.
Publicado: (2021) -
miR-301a promotes lung tumorigenesis by suppressing Runx3
por: Li, Xun, et al.
Publicado: (2019) -
Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling
por: Xiang, Shijian, et al.
Publicado: (2018) -
Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome
por: Pourteymour Fard Tabrizi, Zahra, et al.
Publicado: (2020) -
miR-301a mediated immune evasion by Japanese encephalitis virus
por: Hazra, Bibhabasu, et al.
Publicado: (2017)